Sg Americas Securities, LLC Assertio Holdings, Inc. Transaction History

Sg Americas Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$0.79 - $1.14 $19,069 - $27,517	-24,138 Reduced 43.28%	31,631 $30,000
Q4 2023 Jan 12, 2024	BUY	$1.02 - $2.57 $17,765 - $44,761	17,417 Added 45.41%	55,769 $60,000
Q3 2023 Oct 13, 2023	BUY	$2.52 - $5.69 $96,647 - $218,222	38,352 New	38,352 $98,000
Q4 2022 Feb 02, 2023	SELL	$2.11 - $4.3 $26,799 - $54,614	-12,701 Reduced 14.98%	72,095 $310,000
Q3 2022 Oct 31, 2022	BUY	$2.13 - $4.0 $147,036 - $276,124	69,031 Added 437.88%	84,796 $192,000
Q2 2022 Jul 29, 2022	BUY	$1.88 - $3.42 $29,638 - $53,916	15,765 New	15,765 $47,000

114

37.2M

755K

39.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $58.8M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.